These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 25894172)

  • 21. Effectiveness of febuxostat in patients with allopurinol-refractory hyperuricemic chronic kidney disease
.
    Kwak CH; Sohn M; Han N; Cho YS; Kim YS; Oh JM
    Int J Clin Pharmacol Ther; 2018 Jul; 56(7):321-327. PubMed ID: 29750634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hyperuricemia/gout. Main symptoms of arthropathy. Severe acute joint pain, redness, inflammation].
    Kolyvanos Naumann U; Suter PM; Käser L; Vetter W
    Praxis (Bern 1994); 2005 Apr; 94(14):543-8; quiz 549. PubMed ID: 15849976
    [No Abstract]   [Full Text] [Related]  

  • 23. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.
    Torres RJ; Puig JG
    Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy of febuxostat and allopurinol in the treatment of gout with hyperuricemia.
    Wang S
    Pak J Pharm Sci; 2018 Jul; 31(4(Special)):1623-1627. PubMed ID: 30203749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperuricemia in adult renal allograft recipients: prevalence and predictors.
    Malheiro J; Almeida M; Fonseca I; Martins LS; Pedroso S; Dias L; Henriques AC; Cabrita A
    Transplant Proc; 2012 Oct; 44(8):2369-72. PubMed ID: 23026595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout.
    Dalbeth N; Kumar S; Stamp L; Gow P
    J Rheumatol; 2006 Aug; 33(8):1646-50. PubMed ID: 16783857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hyperuricemia, gout, pseudogout and concomitant diseases].
    Schmidt BM; Wagner AD
    Dtsch Med Wochenschr; 2011 Dec; 136(48):2489-91. PubMed ID: 22109583
    [No Abstract]   [Full Text] [Related]  

  • 28. Uric acid and transplantation.
    Mazzali M
    Semin Nephrol; 2005 Jan; 25(1):50-5. PubMed ID: 15660335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging therapies in the long-term management of hyperuricaemia and gout.
    Stamp LK; O'Donnell JL; Chapman PT
    Intern Med J; 2007 Apr; 37(4):258-66. PubMed ID: 17388867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperuricemia, gout, and renal function after liver transplantation.
    Neal DA; Tom BD; Gimson AE; Gibbs P; Alexander GJ
    Transplantation; 2001 Nov; 72(10):1689-91. PubMed ID: 11726834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CaseBook challenges: Managing gout, hyperuricemia and comorbidities -- dialogue with the experts.
    Bakris GL; Doghramji PP; Keenan RT; Silber SH
    Am J Med; 2014 Jan; 127(1):S1. PubMed ID: 24268074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hyperuricemia. When and how to treat?].
    Reuss-Borst MA
    Internist (Berl); 2016 Feb; 57(2):194-201. PubMed ID: 26791735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout.
    Becker MA; Schumacher HR; MacDonald PA; Lloyd E; Lademacher C
    J Rheumatol; 2009 Jun; 36(6):1273-82. PubMed ID: 19286847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
    Becker MA; Schumacher HR; Wortmann RL; MacDonald PA; Eustace D; Palo WA; Streit J; Joseph-Ridge N
    N Engl J Med; 2005 Dec; 353(23):2450-61. PubMed ID: 16339094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
    Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case 9: initiation of urate-lowering therapy for advanced gout complicated by chronic renal insufficiency.
    Edwards NL
    Am J Med; 2006 Nov; 119(11 Suppl 1):S29-31. PubMed ID: 17059911
    [No Abstract]   [Full Text] [Related]  

  • 37. Gout in pediatric renal transplant recipients.
    Trück J; Laube GF; von Vigier RO; Goetschel P
    Pediatr Nephrol; 2010 Dec; 25(12):2535-8. PubMed ID: 20640905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal transplant-associated hyperuricemia and gout.
    Clive DM
    J Am Soc Nephrol; 2000 May; 11(5):974-979. PubMed ID: 10770978
    [No Abstract]   [Full Text] [Related]  

  • 39. Preservation of renal function during gout treatment with febuxostat: a quantitative study.
    Whelton A; MacDonald PA; Chefo S; Gunawardhana L
    Postgrad Med; 2013 Jan; 125(1):106-14. PubMed ID: 23391676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tophi as the initial manifestation of gout in a normouricemic hemodialysis patient: An unusual case of a common disorder.
    Amine HM
    Saudi J Kidney Dis Transpl; 2017; 28(1):194-195. PubMed ID: 28098129
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.